Clinical Trial Update: Safety and Efficacy of SPD465 in Adults With ADHD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on SPD465 for adults with attention deficit disorder with hyperactivity showing safety and efficacy data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Disorder with Hyperactivity

Drugs mentioned

• SPD465

Snippet

Sponsor: Shire | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 2 | Status: COMPLETED